ESC
MEDP icon

Eurizon SLJ Capital’s Medpace MEDP Stock Holding History

Eurizon SLJ Capital’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5M Sell
9,448
-2,232
-19% -$1.03M 1.85% 17
2026
Q1 		$5.38M Buy
11,680
+1,969
+20% +$1.01M 2.56% 14
2025
Q4 		$5.45M Buy
+9,711
New +$5.51M 2.16% 17

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Eurizon SLJ Capital's MEDP Position: Q2 2026 in Review

Eurizon SLJ Capital reduced its Medpace (MEDP) stake by 19% in Q2 2026, selling an estimated $1.03M and leaving 9,448 shares worth $5M. The position accounts for 1.85% of the portfolio, ranked #17.

Eurizon SLJ Capital first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.45M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Eurizon SLJ Capital held 9,448 shares of Medpace worth $5M as of Q2 2026.
  • Eurizon SLJ Capital sold 2,232 Medpace shares in Q2 2026, an estimated $1.03M.
  • Medpace made up 1.85% of Eurizon SLJ Capital's portfolio in Q2 2026, its #17 holding.
  • Eurizon SLJ Capital first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • Eurizon SLJ Capital's Medpace position peaked at $5.45M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Eurizon SLJ Capital's 13F filing for Q2 2026, filed 3 Aug 2026.